On 5 January, MindFrame announced the issuance of US Patent No. 8,088,140, bringing the total number of patents awarded for its Capture LP thrombectomy technology to three. The previous two patents (8,066,757 and 8,070,791) demonstrate MindFrame’s commitment to developing innovative devices that deliver outstanding outcomes for ischaemic stroke therapy with rapid flow restoration and clot retrieval.
The MindFrame portfolio was recently expanded to include the MindFrame Capture LP 4-mm diameter and multiple shorter-length–sized low profile devices. The MindFrame Capture LP is the first and only device that can be deployed through smaller microcatheters to improve navigation through tortuous vessels.
MindFrame LP devices provide clinicians with unprecedented access to thrombus aspiration locally and proximally as a result of the reduced microcatheter size. In addition, the devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.
MindFrame Capture LP is not approved for sale in the United States.
